|
|
| |
| The Salk Institute Just Made a Big Bet on Alzheimer’s Prevention |
| The Salk Institute — one of the top research labs in the country, down in La Jolla, California — just committed their entire 2026 research program to one question: Can you prevent Alzheimer’s before it starts? |
| Let me explain why this matters to you… |
| The Salk team is running five research tracks at once — cardiovascular health, blood sugar, immune function, exercise, and cognitive load. But all five trace back to one thing: how well your mitochondria are working. |
| Mitochondria are the energy plants inside your cells. Think of them like a power grid for your brain. When the grid works well, your neurons have the juice to repair themselves and clear out waste. When the grid goes down, you get a buildup of junk — inflammation, amyloid plaques — and the slow fade in memory and thinking speed that most folks just blame on age. |
| But what keeps showing up in their data is this… the biggest drivers of a healthy power grid aren’t drugs. They’re the things you already know about — steady blood sugar, a heart that pumps well, moving your body most days, and sleeping deep enough for your brain’s cleanup crew to do its job. |
| |
You see, the old story was that Alzheimer’s is a genetic coin flip. You get the bad genes or you don’t. But the Salk work is pointing in a very different direction. It’s looking more like a slow metabolic failure that builds up over decades. And that’s good news — because you can do something about your metabolism, even in your 50s and 60s. |
|
| I could be wrong, of course. We’re talking about research in progress. But the direction here is clear. And I believe it’s one of the most important stories in brain health right now. |
| I urge you to pay attention to this one. |
| Salk Institute for Biological Studies · June 2026 |
|
|
|
|
| |
| The Simplest Brain Fix I Know |
| Go outside in the morning. |
| Ten minutes before 8 AM, no sunglasses. I know it sounds too easy. But let me explain what happens… |
| Andrew Huberman — a neuroscientist at Stanford — has been talking about this for three years now. And the research keeps backing him up. |
| When sunlight hits your eyes early in the day, it sets off a chain of events. Your body gets a sharp cortisol pulse — the good kind, the one that wakes your brain up and gives you focus all morning. And it starts the clock on melatonin, the hormone that puts you into deep sleep that night. |
| That deep sleep part is what matters most for your brain. During deep sleep, fluid washes through your brain tissue and clears out a protein called amyloid-beta. That’s the same protein that builds up in Alzheimer’s patients. Miss that deep sleep and the waste just sits there… and over time, it piles up. |
| And the whole process starts with that morning light. |
| The Protocol |
| When |
Within 60 minutes of waking |
|
| Duration |
10 min sunny · 20 min overcast |
|
| Rules |
Face the sun, don’t stare at it. No sunglasses. Glasses and contacts are fine. |
|
| |
| Try it for five mornings in a row. Watch two things — your energy around 2 PM, and how fast you fall asleep at night. If you notice a difference, your internal clock is getting back on track. It’s free and it takes ten minutes. I urge you to try it. |
|
|
|
|
|
|
|
| Your gut is telling your brain what to eat |
| Researchers found a direct line from the gut to the brain that fires when your protein drops too low. It shuts down sugar cravings and makes you want amino acids instead. This isn’t willpower — it’s wiring. Your gut has more control over your food choices than most people realize. |
| ScienceDaily · May 28, 2026 |
|
|
| A popular anti-aging drug stack just failed badly in mice |
| A combo making the rounds in longevity circles stripped myelin off mouse brain cells. Myelin is the insulation that lets your neurons fire fast and clean. Without it, your thinking slows down. Researchers compared the damage to chemo brain. If you’re taking rapamycin or metformin combos, take a hard look at this one. |
| ScienceDaily · May 27, 2026 |
|
|
| A new form of vitamin K helped brains repair themselves in the lab |
| Early-stage research — far from the clinic — but the approach is smart. Instead of adding a new drug, this compound works with your brain’s own repair systems. That’s a direction worth watching. |
| ScienceDaily · May 2026 |
|
|
|
|
| |
| There are 158 drugs being tested for Alzheimer’s right now — 40% more than a decade ago. Most of them are no longer just trying to treat the disease after it starts. They’re trying to prevent it. Here are three worth knowing about: |
|
| A plaque-clearing drug is now being tested on healthy people |
| Eli Lilly makes a drug called donanemab that clears amyloid plaques from the brain — the sticky buildup linked to Alzheimer’s. It’s already approved in the UK for people who have the disease. But the big trial right now is testing whether it works in people who don’t have symptoms yet… people who are at risk but still feel fine. If this pans out, it changes when you’d want to get screened. We could have answers this year. |
| Late-stage trial · Results expected 2026 |
|
|
| Another early-treatment drug is being tested before symptoms show up |
| A drug called Leqembi, made by Eisai and Biogen, works similarly — it goes after amyloid in the brain. The trial that matters is called AHEAD, and it’s testing the drug in people who carry risk factors but haven’t shown any signs of memory loss. The question is simple: can you treat Alzheimer’s the way you treat heart disease — catch it early and slow it down before the damage is done? |
| Late-stage trial · Ongoing |
|
|
| Researchers are now attacking two Alzheimer’s proteins at once |
| Most drugs go after one target. This trial combines a vaccine that trains your immune system to fight a protein called tau with a drug that clears amyloid. Think of it like treating a fire from two sides instead of one. It’s still early — no results for a while — but the logic behind it is sound, and I expect we’ll see more combination approaches like this going forward. |
| Early-stage trial · Worth watching |
|
|
